Geographic Atrophy: all 188 studies
Page 2 of 2. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.
- Geographic Atrophy Treatment EvaluationTerminatedNCT00890097Phase 3Results posted
- Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMDCompletedNCT00766649Phase 1/2Results posted
- Fluocinolone Acetonide Intravitreal Inserts in Geographic AtrophyTerminatedNCT00695318Phase 2Results posted
- OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular DegenerationCompletedNCT00306488Phase 2Results posted
- Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular DegenerationCompletedNCT07428798Not applicable
- Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History CohortCompletedNCT07424235
- Ocular Proteomics Testing In Chronic AtrophyActive, not recruitingNCT07298291Not applicable
- Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled SyringeCompletedNCT07214740Phase 3
- A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular DegenerationActive, not recruitingNCT06970665Phase 4
- A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)TerminatedNCT06961370Phase 1
- The GA in HSI StudyCompletedNCT06860568
- A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic AtrophyActive, not recruitingNCT06779773
- A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyActive, not recruitingNCT06769048Phase 2
- A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyCompletedNCT06722157Phase 2
- A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)Active, not recruitingNCT06510816Phase 3
- Geographic Atrophy Long-Terms Outcomes StudyCompletedNCT06499571
- Evaluation of Kamuvudine-8 in Subjects With Geographic AtrophyCompletedNCT06164587Phase 1/2
- A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular DegenerationActive, not recruitingNCT06161584
- Phase 1/2 Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular DegenerationActive, not recruitingNCT06087458Phase 1/2
- Study to Assess the Safety and Efficacy of OCU410 for Geographic AtrophyActive, not recruitingNCT06018558Phase 1/2
- A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyCompletedNCT06006585Phase 1
- Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy StudyCompletedNCT05963646
- Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic AtrophyActive, not recruitingNCT05949593Phase 3
- A Study of the SING IMT in an Israeli CohortWithdrawnNCT05941273Not applicable
- A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT05839041Phase 2
- A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)CompletedNCT05811351Phase 2
- Investigating Geographic Atrophy Insights (i-GAIN) Natural History StudyCompletedNCT05797896
- Oral Postbiotics in Patients With Macular AtrophyStatus unknownNCT05391074Not applicable
- Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular DegenerationActive, not recruitingNCT05380492Phase 1/2
- A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular DegenerationCompletedNCT05230537Phase 2
- Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular DegenerationActive, not recruitingNCT04796545Not applicable
- ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular DegenerationCompletedNCT04744662Phase 1
- Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMDActive, not recruitingNCT04676854Not applicable
- A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular DegenerationTerminatedNCT04643886Phase 2
- Prediction of Progression of Age-Related Macular DegenerationStatus unknownNCT04640649Not applicable
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema PatientsCompletedNCT04635800Phase 1
- A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationCompletedNCT04615325Phase 1
- Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)WithdrawnNCT04358471Phase 2
- First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular DegenerationCompletedNCT04246866Phase 1
- Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular DegenerationCompletedNCT04084587Not applicable
- Study of NGM621 in Participants With Geographic AtrophyCompletedNCT04014777Phase 1
- GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)TerminatedNCT03894020
- GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT03815825Phase 2
- Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic AtrophyCompletedNCT03777332Phase 1
- Non Exudative AMD Imaged With SS-OCTStatus unknownNCT03688243
- Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)WithdrawnNCT03446144Phase 2
- PRIMA US-Feasibility Study in Atrophic Dry AMDCompletedNCT03392324Not applicable
- Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular DegenerationCompletedNCT03333954Not applicable
- Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT03295877Phase 1
- Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59CompletedNCT03144999Phase 1
- Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)WithdrawnNCT02895815Phase 2
- BioCurrent Electrical Stimulation for the Treatment of Dry ARMDWithdrawnNCT02699216Not applicable
- Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMDStatus unknownNCT02590692Phase 1/2
- A Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular DegenerationTerminatedNCT02479386
- Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMDCompletedNCT02463344
- A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular DegenerationTerminatedNCT02399072
- Geographic Atrophy and Intravitreal Ranibizumab InjectionsStatus unknownNCT02372916
- Sparing of the Fovea in Geographic Atrophy ProgressionCompletedNCT02332343
- Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular DegenerationTerminatedNCT02137915
- Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular DegenerationCompletedNCT02130531Phase 1
- Directional Spread in Geographic AtrophyCompletedNCT02051998
- Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular DegenerationWithdrawnNCT02036723Phase 3
- Pharmacokinetic (PK) Study of GSK933776 in Healthy VolunteersCompletedNCT02033668Phase 1
- Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular DegenerationWithdrawnNCT02024269Not applicable
- Stem Cell Ophthalmology Treatment StudyStatus unknownNCT01920867Not applicable
- Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment EpitheliumCompletedNCT01890187
- Safety and Efficacy Assessment Treatment Trials of Emixustat HydrochlorideCompletedNCT01802866Phase 2/3
- Micropulse Laser for Geographic AtrophyCompletedNCT01799564Not applicable
- Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)CompletedNCT01782989Phase 2/3
- Evolution and Risk Factors Associated With Geographic Atrophy ProgressionCompletedNCT01694095
- Intravitreal Injections of Sirolimus in the Treatment of Geographic AtrophyTerminatedNCT01675947Phase 2
- A Population-based Study of Macular Choroidal Neovascularization in a Chinese PopulationCompletedNCT01666821
- Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular DegenerationCompletedNCT01344993Phase 1/2
- Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)TerminatedNCT01337414Not applicable
- Seven Year Update of Macular Degeneration PatientsCompletedNCT01256827
- Intravitreal LFG316 in Patients With Advanced Age-related Macular DegenerationCompletedNCT01255462Phase 1
- A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic AtrophyCompletedNCT01229215Phase 2
- A Safety Study of CNTO 2476 in Patients With Age-Related Macular DegenerationCompletedNCT01226628Phase 1/2
- GARM II: A Study on the Genetics of Age-related MaculopathyActive, not recruitingNCT01115387
- A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic AtrophyWithdrawnNCT01093170Phase 1
- Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic AtrophyCompletedNCT01002950Phase 2
- A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic AtrophyCompletedNCT00973011Phase 1
- The Natural History of Geographic Atrophy Progression (GAP) StudyTerminatedNCT00599846
- The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)Status unknownNCT00485394Phase 2
- Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular DegenerationCompletedNCT00429936Phase 2
- Selective RPE Laser Treatment (SRT) for Various Macular DiseasesStatus unknownNCT00403884Not applicable
- Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser OphthalmoscopyCompletedNCT00393692
- Genetic Study of Age-Related Macular DegenerationCompletedNCT00357578